SecBot SecBot

PRVA

Privia Health Group, Inc.
Nasdaq· Services-Health Services· Inc. DE· CIK 0001759655 Healthcare & Medical Devices
$25.26 +0.71 (+2.89%)
Nov 16 4:00 PM ET · prev $24.55
Market cap
$3.0B
Mid cap
Consensus
Buy
92% Buy or better · 24 analysts
Median target
$31.00
+23% · range $24.00–38.00
1 year
+8.8%
from $23.22 · Nov 17
30 days
+12.6%
from $22.44
52-week range
$19.10–28.10
−10% from high · low Sep 23
Avg volume 20D
1.36M
shares / day
Short interest
3.90M
≈3.0% of shares · −22.2%
Days to cover
4.5
at average volume
Insider net
−$15.7M
0 buyers · 3 sellers · since May 1
New fund stakes
2
Q3 2026 13F · 1 exit
Filing reports
18
analyzed by SecBot
SecBot read BEARISH 5 reports · 90 days
Balance 1 bearish · 0 bullish · 1 mixed · 3 neutral oldest → newest, height = score
Avg score ·High conf. 4/5

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    3 insiders sold $15.7M.

  • InstitutionsBULLISH

    Q3 2026: 26 added (2 new), 15 trimmed or exited. Largest new: Hrt Financial $10.5M.

  • AnalystsBULLISH

    22 of 24 rate it Buy or better. Median target $31.00 (+23%).

  • Short sellersCOVERING

    Short interest −22.2% to 3.90M shares. 4.5 days to cover, ≈3.0% of shares.

  • TrendUPTREND

    18% above its 50-day average.

Who's buying

13F· Q3 2026
2
new positions
1
exit
$10.5M
in new stakes · top 1 shown
FundMoveSharesValue
FMR LLCTRIM6,830,627$134.5M
LOOMIS SAYLES & CO L PDOUBLED2,035,244$40.1M
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ADD1,739,427$34.2M
FRANKLIN TEMPLETON INCTRIM899,573$20.2M
HRT FINANCIAL LPNEW531,612$10.5M
FIRST TRUST ADVISORS LPADD435,451$8.6M
LOS ANGELES CAPITAL MANAGEMENT LLCDOUBLED401,838$7.9M
Squarepoint Ops LLCADD387,744$7.6M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

24 analysts
Buy 92% rate it Buy or better
Strong Buy7Buy15Hold2Sell0Strong Sell0
12-month targets · 17 analysts

Price is inside the target range. Median implies +23%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 6, 2026Canaccord Genuity
MAINTAIN
MAINTAINBuy
Nov 6, 2026Piper Sandler
MAINTAIN
MAINTAINOverweight
May 26, 2026Barclays
MAINTAIN
MAINTAINEqual-Weight

Insider ledger

Form 4
$0
bought · 0 insiders
$15.7M
sold · 3 insiders
DateInsiderTypeValue
Sep 1, 2026
Ernest Opella Finley
Director
Sep 1, 2026
AWARD6,350 sh
Jul 9, 2026
Mountcastle David
EVP & Chief Financial Officer
Jul 9, 2026
SELL$588.7K
Jul 7, 2026
Mountcastle David
EVP & Chief Financial Officer
Jul 7, 2026
SELL$16.5K
Jul 6, 2026
Morris Matthew Shawn
Director
Jul 6, 2026
EXERCISE$107.4K
Jul 6, 2026
Morris Matthew Shawn
Director
Jul 6, 2026
SELL$1.5M
Jul 2, 2026
Mountcastle David
EVP & Chief Financial Officer
Jul 2, 2026
SELL$680.2K
Jul 2, 2026
Morris Matthew Shawn
Director
Jul 2, 2026
EXERCISE$118.1K
Jul 2, 2026
Morris Matthew Shawn
Director
Jul 2, 2026
SELL$1.6M

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 30, 2026
3,898,083
shares short
-22.2%
vs prior settlement
4.5
days to cover
≈3.0%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

18 filings · 2 press releases · 1 bullish · 4 bearish · 2 mixed · 11 neutral
All PRVA filing & press-release reports (20)